期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 345, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jneuroim.2020.577281
关键词
Multiple sclerosis; Experimental autoimmune encephalomyelitis; T-regulatory cells (Tregs); B-regulatory cells (Bregs); Granulocyte-macrophage colony-stimulating factor (GM-CSF); Glatiramer acetate (GA)
资金
- Teva Pharmaceuticals
To identify the mechanisms relevant for the therapeutic effect of glatiramer acetate (GA), we studied T- and B-regulatory cells as well as GM-CSF expression in mice recovered from experimental autoimmune encephalomyelitis (EAE). Selective depletion of Tregs reduced but did not eliminate the ability of GA to ameliorate EAE, indicating a role for additional immune-subsets. The prevalence of Bregs in the periphery and the CNS of EAE-mice increased following GA-treatment. Furthermore, GA downregulated the pathological expression of GM-CSF, on both the protein and mRNA levels. These findings corroborate the broad immunomodulatory mechanism of action of GA in EAE/MS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据